These findings highlight the value of canFam4-based profiling in identifying immune regulatory programs and suggest that CEACAM1+CD24+ granulocytes may warrant further investigation in canine models of infection, inflammation, and cancer. This evidence concerns the gene CEACAM1 and cancer.